Harman-d3 - HY-W700834

Catalog #
HY-W700834
 
Harman-d3 is deuterium labeled Harmane. Harmane is a benzodiazepine receptor inhibitor (IC50=7 μM), with IC50 values for mACh, Opioid Receptor, MAO-A/B, and α2-adrenergic receptor of 24 μM, 2.8 μM, 0.5 μM, 5 μM, and 18 μM, respectively. Harmane also inhibits haloperidol and serotonin, with IC50 values of 163 μM and 101 μM, respectively. Harmane inhibits the I1 imidazoline receptor (IC50=30 nM) to reduce blood pressure and has antidepressant, anti-anxiety, anticonvulsant, and analgesic effects. Harmane inhibits dopamine biosynthesis by decreasing tyrosine hydroxylase (TH) activity and enhancing L-DOPA-induced cytotoxicity in PC12 cells. Additionally, Harmane can increase the mutagenic effect induced by 2-acetylaminofluorene (AAF)[1][2][3][4][5][6].
Weitere Informationen
Datasheet URL http://file.medchemexpress.com/batch_PDF/HY-W700834/Harman-d3-DataSheet-MedChemExpress.pdf
Quantity Get quote
Shipping Room temperature
Application COVID-19-immunoregulation
CAS 1216708-84-7
MWT 185.24
Clinical Information No Development Reported
Target Isotope-Labeled Compounds
Applications
Application: COVID-19-immunoregulation

Newsletter
abonnieren

15% Rabatt

erhalten